Columbia University Human Research Protection Program
Policies and Guidance
Selected University Research Policies & Guidances
Principal Investigator Eligibility Policy
Risk Management Procedures for International Research and Service Projects
Short-term Visitors in Research-related Activities Guidelines
Sponsored Project's Handbook
- Conflict of Interest Policies
CUMC Conflict of Interest Policy
Guidelines for Situations Involving Potential Conflicts of Interest Between Scholarly and Commercial Activitie
Sample Disclosure Forms
Statement of University Policy on Conflicts of Interest
- New York Presbyterian Hospital (NYP) Policies
NYPH Policy: Use and Control of Investigational Drugs
NYPH Policy: Emergency Use of an Investigational Drug or Biological Product
Listserv message (July 9, 2009) regarding NYP Safety Reporting for Research Studies
Incident Reporting to the New York State Department of Health
Serious Adverse Events/Sentinel Events (SAE/SE)
NYPH Policy: Research Drugs (Investigational or Commercially Available) from Protocols Originating at Other
Institutions
- CUMC Research Pharmacy Policies
Investigational Drugs- Inpatient
Investigational Drugs- Outpatient
Memo Regarding Policy for
Review of Research by Western IRB
For research safety policies please consult with the Environmental Health and Safety website
IRB Policies, Procedures, and Guidance
General
Investigator Responsibilities
List of Guidances for IRBs, Investigators, & Sponsors
Risks
International Standards
Related Information
Timeline of Laws Related to the Protection of Human Subjects
Archive
Adverse Event Reporting Policy, 4/13/2004 version
Enrollment of Non-English Speaking Subjects in Research, 12/6/2006 version
Informed Consent Policy, 5/8/07 version
Investigational Devices:
IRB Procedures for obtaining CMS Approval
IRB Standard Operating Procedures, 6/9/2008 version
IRB Standard Operating Procedures, 12/15/2008 version
WIRB Review |